Type 2 diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Confirmation of type 2 diabetes (fasting blood sugar greater than 126 mg / dL, oral glucose tolerance test equal to or greater than 200 mg / dL, glycosylated hemoglobin 5.6% or higher) Body mass index between 27 Up to 35, age 40 to 60 years
Exclusion criteria
Exclusion criteria: Insulin use, having cardiovascular disease, musculoskeletal disease, liver disease, kidney disease, thyroid disorder, having a history of regular physical activity for at least the last six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 6. Timepoint: Before the intervention and 48 hours after the intervention. Method of measurement: Biochemical and laboratory methods.;Adipolin. Timepoint: Before the intervention and 48 hours after the intervention. Method of measurement: Biochemical and laboratory methods.;Secreted frizzled-related protein 5. Timepoint: Before the intervention and 48 hours after the intervention. Method of measurement: Biochemical and laboratory methods. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood glucose. Timepoint: Before and after the protocol. Method of measurement: Mg /dL by blood test.;Triglyceride. Timepoint: Before and after the protocol. Method of measurement: Laboratory and biochemical methods.;Low density lipoprotein cholesterol. Timepoint: Before and after the protocol. Method of measurement: Laboratory and biochemical methods.;High-density lipoprotein cholesterol. Timepoint: Before and after the protocol. Method of measurement: Laboratory and biochemical methods.;Insulin. Timepoint: Before and after the protocol. Method of measurement: Laboratory and biochemical methods. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University of Khorasgan Branch